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ABSTRACT
Introduction: Homocysteine (Hcy) tissue accumulation occurs in a metabolic disease 
characterized biochemically by cystathionine β-synthase (CBS) deficiency and clinically 
by mental retardation, vascular problems, and skeletal abnormalities. Previous studies 
indicate the occurrence of DNA damage secondary to hyperhomocysteinemia and it 
was observed that DNA damage occurs in leukocytes from CBS-deficient patients. 
This study aimed to investigate whether an oxidative mechanism could be involved in 
DNA damage previously found and investigated the in vitro effect of N-acety-L-cysteine 
(NAC) on DNA damage caused by high Hcy levels.
Methods: We evaluated a biomarker of oxidative DNA damage in the urine of 
CBS-deficient patients, as well as the in vitro effect of NAC on DNA damage caused 
by high levels of Hcy. Moreover, a biomarker of lipid oxidative damage was also 
measured in urine of CBS deficient patients.
Results: There was an increase in parameters of DNA (8-oxo-7,8-dihydro-2’-
deoxyguanosine) and lipid (15-F2t-isoprostanes levels) oxidative damage in CBS-deficient 
patients when compared to controls. In addition, a significant positive correlation was 
found between 15-F2t-isoprostanes levels and total Hcy concentrations. Besides, an 
in vitro protective effect of NAC at concentrations of 1 and 5 mM was observed on DNA 
damage caused by Hcy 50 µM and 200 µM. Additionally, we showed a decrease in 
sulfhydryl content in plasma from CBS-deficient patients when compared to controls.
Discussion: These results demonstrated that DNA damage occurs by an oxidative 
mechanism in CBS deficiency together with lipid oxidative damage, highlighting the 
NAC beneficial action upon DNA oxidative process, contributing with a new treatment 
perspective of the patients affected by classic homocystinuria.
Keywords: Cystathionine-β-synthase deficiency; oxidative stress; 8-oxo-7,8-dihydro-
2’-deoxyguanosine; homocysteine; DNA damage; N-acetyl-L-cysteine
Cystathionine beta synthase (CBS) deficiency (classic homocystinuria) is 
biochemically characterized by elevated levels of circulating homocysteine (Hcy) 
and methionine, S-adenosylmethionine and S-adenosyl homocysteine, as well 
as reduced circulating levels of cystathionine and cysteine1. CBS deficiency 
has an estimated worldwide incidence of 1:344,000 live births and has 
autosomal recessive inheritance2.
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Some patients affected by classic homocystinuria 
have small residual CBS activity, whereas other 
patients with CBS deficiency have no such enzyme 
activity detected by even the most sensitive methods1. 
The eye, skeleton, central nervous system, and 
vascular system are all involved in the typical 
presentation. The patient is normal at birth and, if 
not treated, progressively develops the full clinical 
picture3.The recommended treatment modalities for 
this disease include pyridoxine in combination with 
folic acid and/or B12 vitamin and/or betaine, as well 
as methionine-restricted diet supplemented with 
cysteine2. Probably, both early diagnosis and strict 
compliance to treatment will change the natural 
history of cardiovascular and mental symptoms even 
in pyridoxine-nonresponsive individuals. Although 
various mechanisms have been proposed to explain 
the pathophysiology of CBS deficiency, this issue has 
not been completely elucidated. However, accumulation 
of total homocysteine (tHcy) probably plays a major 
role in determining some of the most relevant clinical 
manifestations, particularly generalized vascular 
damage and thromboembolic complications in patients 
affected by CBS deficiency3. In a recent study, we 
have demonstrated the importance of B12 vitamin in 
some biochemical parameters and of folic acid in 
reducing plasma tHcy levels in CBS-deficient patients4.
Hcy is a sulphydryl amino acid that oxides readily 
to its disulphide form (homocystine). In normal plasma, 
Hcy exists in various forms: the sulphydryl form 
(approximately 1%), bound to the cysteine residues 
of proteins (approximately 70%), and bound to free 
cysteine as cysteine-Hcy mixed disulphide (approximately 
30%). When Hcy levels are elevated, its disulphide 
form (homocystine) is formed. Homocystine renal 
tubular reabsorption is very inefficient in patients 
with severe untreated CBS deficiency and more than 
1 mmol of this disulfide may be excreted each day1. 
Normal plasma tHcy values are less than 15 µmol/L, 
whereas most untreated CBS-deficient patients 
exhibit levels above 200 µmol/L. In plasma, tHcy is 
the sum of free and protein-bound homocysteine, 
homocystine, and several other mixed disulfides3.
Free radicals and other reactive species are 
widely believed to contribute to the development of 
several diseases5,6. In what concerns homocystinuria, 
some studies performed in animal models showed 
the involvement of oxidative stress7,8 and some 
reports described oxidative damage induced by Hcy 
and Hcy thiolactone in neurons and in HL-60 cells, 
respectively9,10. Moreover, it was previously demonstrated 
that lipid and protein oxidative damage are increased 
and antioxidant defenses are decreased in plasma 
of CBS-deficient patients, probably due an increase 
of reactive species generation induced by tHcy11. 
Besides, it was observed that DNA damage occurs 
in leukocytes from CBS-deficient patients, but it was 
not investigated whether the mechanism that induced 
damage had an oxidative origin12.
Guanine is the nucleobase most prone to 
oxidation, and 8-oxo-7,8-dihydro-2’-deoxyguanosine 
(from DNA) is the form of oxidized guanine that is 
most commonly studied. In recent years, it has been 
shown that both DNA and RNA are damaged by 
oxidation in disease states, and that repair processes 
which are initiated to correct this damage lead to a 
release of multiple oxidized guanine species into the 
urine, including the ribose-free base (8-oxo-guanine 
or 8-hydroxyguanine), the nucleoside from RNA 
(8-oxo-7,8-dihydroguanosine), and the deoxynucleoside 
from DNA (8-oxo-7,8-dihydro-2’-deoxyguanosine)13.
The thiol N-acetyl-L-cysteine (NAC) is an antioxidant 
that is readily deacetylated in cells to yield L-cysteine, 
thereby promoting intracellular reduced glutathione 
(GSH) synthesis. Reduced glutathione plays a central 
physiological role in maintaining body homeostasis 
and in protecting cells against oxidants, toxicants, 
DNA-damaging agents, and carcinogens of either 
exogenous or endogenous source. Besides, acting 
as a GSH precursor, NAC is, per se, responsible for 
protective effects in the extracellular environment, mainly 
due to its nucleophilic and antioxidant properties14.
Considering the points raised above, this study aimed 
to evaluate the urinary biomarker of oxidative damage 
to DNA (8-oxo-7,8-dihydro-2’-deoxyguanosine), as 
well as lipid peroxidation marker (15-F2t-isoprostane) 
in urine from CBS-deficient patients to investigate 
whether an oxidative mechanism could be involved 
in DNA damage. We also assessed the in vitro effect 
of NAC on DNA damage caused by high Hcy levels.
METHODS
In vivo Study
Patients and controls
Occasional urine and blood samples were collected 
from 11 CBS-deficient patients (median age: 17 years; 
range: 11-33 years). All of them received treatment 
with supplementation of pyridoxine (median dose: 
500 mg/day; range: 100-750 mg/day), folic acid 
(median dose: 5 mg/day; range 2-5 mg/day), betaine 
(median dose: 6 g/day; range: 2-6 g/day) and vitamin 
B12 (median dose: 1 mg/month, intramuscularly), in 
addition to a protein-restricted diet. The mean time 
on treatment was 13 years (range: 1-22 years) and 
the average plasmatic levels of tHcy in those patients 
was 191.3±105.3 µmol/L (mean ± standard deviation).
CBS-deficient homocystinuric patients enrolled in 
this study were being followed-up in the Service of 
Medical Genetics of Hospital de Clínicas de Porto Alegre, 
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Brazil. Patients’ diagnosis was made by the abnormal 
concentrations of tHcy and methionine identified in 
plasma. Predominantly, clinical presentations were 
characterized by neuropsychomotor alterations – such as 
developmental delay and seizures –, ectopia lentis, 
and a marfanoid appearance (lengthening and 
thinning of long bones).
For the control group, samples from nine 
healthy age- and sex-matched individuals (median 
age: 22 years; range: 15-30 years) were collected. 
These individuals were recruited from the Laboratory 
of Clinical Analyses da Universidade Federal do Rio 
Grande do Sul.
This study was approved by the Ethics Committee 
of Hospital de Clínicas de Porto Alegre, Brazil, and 
registered under the number 10-0290. Written informed 
consent was obtained from all patients and healthy 
individuals participating in the study, according to 
the Ethics Committee guidelines.
Urine collection
Occasional urine samples were obtained from 
individuals (controls and CBS-deficient patients) and 
frozen at -80ºC until analysis.
Blood collection
Blood samples were collected from healthy individuals 
and CBS-deficient patients into heparinized tubes by 
venous puncture. Whole blood was centrifuged at 
3,000 x g for 10 min at 4 ºC, and the clear plasma 
was aspirated, aliquoted and kept frozen (-80ºC) 
until analysis.
8-oxo-7,8-dihydro-2’-deoxyguanosine 
(8-oxodG)
Urinary 8-hydroxy-2’-deoxyguanosine (from DNA), 
8- hydroxyguanosine (from RNA) and 8-hydroxyguanine 
(from DNA and RNA) levels were determined by 
the DNA/RNA oxidative damage enzyme-linked 
immunoassay (ELISA) kit (Cayman Chemical, 
USA). This urinary assay is based on a competitive 
in vitro enzyme-linked immunosorbent assay 
between oxidatively damaged guanine species 
and an 8-OH-dG-acetylcholinesterase conjugate 
(DNA/RNA oxidative damage tracer) for a limited 
about of DNA/RNA oxidative damage monoclonal 
antibody. Results were expressed as ng per mg 
urinary creatinine.
15-F2t-isoprostane determination
15-F2t-isoprostane was measured by a competitive 
ELISA between the 15-F2t-isoprostane in the sample 
and the 15-F2t-isoprostane conjugated to horseradish 
peroxidase (HRP) for binding to a specific polyclonal 
antibody fixed on the microplate (Oxford Biomed, 
EA 85). The concentration of 15-F2t-isoprostane was 
determined by the intensity of color developed after 
the addition of substrate (wavelength at 630 nm) and 
was reported as nanograms of isoprostanes per mg 
urinary creatinine.
Urine creatinine determination
Urine creatinine determination was performed 
by a picric acid method (kit by Labtest Diagnóstica, 
Minas Gerais, Brazil). The concentrations were 
represented as mg/dL.
Total homocysteine (tHcy) measurement
Total homocysteine levels in plasma, the sum of 
free and protein-bound homocysteine, homocystine, 
and several other mixed disulfides were measured 
by liquid chromatography electrospray tandem 
mass spectrometry (LC-MS/MS), as described by 
Magera et al.15. The results were expressed as 
μmol/L.
Sulfhydryl content measurement
Thirty microliters of 5.5’-dithio-bis (2-nitrobenzoic 
acid) (DTNB) were incubated with an equal volume 
of plasma at room temperature for 30 minutes in a 
dark room. The reduction of DTNB by thiols produces 
a yellow derivative (2-nitro-5-thiobenzoate – TNB) 
whose absorption is measured spectrophotometrically 
(412 nm)16. The sulfhydryl content is inversely 
correlated to oxidative damage to proteins and was 
reported as nmol TNB/mg protein.
In vitro study
Venous blood from five healthy volunteers 
individuals was collected under sterile conditions 
into heparinized tubes. Whole blood cells from 
each subject were incubated without Hcy and NAC 
(control group), with different concentration of Hcy 
(50 and 200 µM), and in a co-treatment with Hcy 
(50 and 200 µM) and NAC (1 and 5 mM) for 6 h at 
37 ºC 17,18. The Hcy concentrations were based on 
levels found in blood from treated CBS-deficient 
patients, since the CBS-deficient patients who have 
good treatment adherence present tHcy levels around 
50 µM, and the individuals who do not have good 
treatment adherence present tHcy levels around 
200 µM1.
Single cell gel electrophoresis (comet assay)
The alkaline comet assay was carried out as 
described by Singh et al.19 in conformity with the 
general guidelines for use of the comet assay17,18. 
Aliquots of 100 µL from whole blood previously 
incubated with or without Hcy and/or NAC were 
suspended in agarose and spread into a glass 
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microscope slide pre-coated with agarose to perform 
the comet assay17-20. In each slide, 100 cells were 
microscopically analyzed and the damage class of 
each cell was determined. The damage classes were 
classified into: 0 = no tail (no damage); 1 = small 
tail (smaller than the diameter of the head); 2 = tail 
length between one and two times the diameter of the 
head; 3 = long tail (greater than twice the diameter 
of the head); 4 = long tail and more widespread than 
class 3. Subsequently, the number of cells found in 
each damage class was multiplied by the number 
of the corresponding class. The damage index (DI) 
was determined by the sum of these multiplications. 
The slides were analyzed under blind conditions at 
least by two different individuals.
STATISTICAL ANALYSIS
In vivo Study
All the analyses were performed using the Statistical 
Package for Social Sciences (SPSS) software. Results 
were expressed as mean ± standard deviation and 
the comparison between means was analyzed by the 
Student’s t test for unpaired samples. Correlations 
between variables were performed by Pearson 
correlation test. A p value of less than 0.05 was 
considered significant.
In vitro Study
Comet assay data were expressed as mean ± standard 
deviation and were calculated by one-way ANOVA 
followed by the Duncan post roc test, when the 
F value was significant. A p value lower than 0.05 was 
considered significant. All analyses were performed 
using the SPSS software.
RESULTS
The 8-oxo-7,8-dihydro-2’-deoxyguanosine levels 
were significantly higher in CBS-deficient patients 
when compared to controls [t(12)= 2.636, p < 0.05], 
indicating DNA damage by an oxidative mechanism. 
Similarly, 15-F2t-isoprostanes levels, a parameter of 
oxidative damage to lipids, were significantly higher 
in CBS-deficient patients when compared to controls 
[t(15)= 2.458, p < 0.05]. We found a significant positive 
correlation between 15-F2t-isoprostanes levels and 
tHcy levels (r = 0,780, p < 0.05), indicating that Hcy 
seems to induce oxidative damage (Figure 1).
In this study, we also evaluated the in vitro effect 
of NAC on DNA damage caused by high levels of 
Hcy. We found a significantly higher DNA damage 
induced by 50 and 200 µM of Hcy compared 
to the control group and observed that NAC at 
1 and 5 mM concentrations was able to significantly 
decrease the DNA damage caused by Hcy 50 µM and 
Hcy 200 µM (Figure 2). Furthermore, we demonstrated 
that sulfhydryl content was significantly lower in 
plasma of CBS-deficient patients when compared 
to controls [t(18)= 2.370, p<0.05] (Figure 3).
Figure 1: Oxidative damage to DNA [8-oxo-7,8-dihydro-2’-
deoxyguanosine levels (A)] and lipids [15-F2t-isoprostanes 
levels (B)] in urine from CBS-deficient patients and controls. 
Data represent the mean ± standard deviation (controls: 
n = 7-9; patients: n = 7-9). *p < 0.05, compared to controls 
(Student’s t test for unpaired samples). (C) Correlation 
between urinary 15-F2t-isoprostanes levels and plasma 
tHcy levels from CBS- deficient patients.
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DISCUSSION
Oxidative stress has been related to the 
pathophysiology of various inborn errors of metabolism21. 
In this study, an important biomarker of oxidative 
DNA damage (8-oxodG) was investigated in urine 
samples from CBS-deficient patients. Moreover, we 
evaluated the in vitro effect of NAC on DNA damage 
induced by high Hcy concentrations. Isoprostanes, 
an urinary biomarker of lipid peroxidation, as 
well as sulfhydryl content, were also analyzed in 
CBS-deficient patients.
Recent studies indicate the occurrence of 
DNA damage secondary to hyperhomocysteinemia: 
Lin et al.22 demonstrated the synergic actions of Hcy 
and S-adenosylhomocysteine (SAH) on DNA damage 
in a murine microglial cell line through a mechanism 
involving reactive oxygen species (ROS), and 
Huang et al.10 showed that Hcy induces apoptotic 
DNA damage in HL-60 cells mediated by increased 
intracellular generation of H2O2. In the present 
study, by using urinary 8-oxodG measurement, we 
intended to investigate whether the DNA damage 
found in CBS-deficient patients is established by 
an oxidative mechanism. It was demonstrated that 
oxidative DNA damage occurs in CBS-deficient 
patients, since they presented a significant increase 
in urinary 8-oxodG levels compared to controls. 
Oxidative DNA damage results of the attack by ROS 
in both nuclear and mitochondrial DNA, producing 
predominantly an oxidized form of guanosine, 
the 8-oxodG23. The oxidized DNA is continuously 
repaired, and the oxidized nucleoside is excreted 
into the bloodstream and into urine; 8-oxodG reflects 
the equilibrium between its production and repair 
in both DNA and the nucleotide pool24. 8-oxodG is 
the most sensitive marker of oxidative DNA damage 
and reflects total systemic oxidative stress in vivo25. 
In addition, 8-oxodG is an established risk marker 
for atherosclerosis and diabetes mellitus and it has 
been shown that urinary 8-oxodG is more stable 
than serum 8-oxodG26.
Considering the oxidative DNA damage found 
in CBS-deficient patients, we also evaluated 
the effect of NAC on DNA damage caused by 
50 and 200 µM concentrations of Hcy. NAC at 
1 and 5 mM concentrations was able to significantly 
reduce the damage caused by Hcy 50 and 200 µM, 
evidencing an antioxidant effect of that molecule. 
Studies provide evidence that NAC has antigenotoxic 
and anticarcinogenic properties in several experimental 
models27. As a source of sulfhydryl groups, which 
neutralize ROS, NAC plays a critical role in 
Figure 2: In vitro effect of NAC at 1 and 5 mM concentrations on 
DNA damage caused by Hcy 50 µM (A) and Hcy 200 µM (B). 
Data represent the mean ± standard deviation of three 
independent experiments. (a) p < 0.05, compared to 
control (without Hcy and NAC), (b) p < 0.05, compared 
to Hcy 50 µM or Hcy 200 µM (one-way ANOVA, followed 
by Duncan test).
Figure 3: Sulfhydryl content in plasma from CBS-deficient 
patients and controls. Data represent the mean ± standard 
deviation (controls: n = 9; patients: n = 11). *p < 0.05, 
compared to controls (Student’s t test for unpaired samples).
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regulating the oxidant/antioxidant balance directly 
and in decreasing cell oxidative stress28. Since 
we demonstrated in this study that CBS-deficient 
patients have reduced sulfhydryl group levels, 
NAC supplementation could be beneficial during 
the treatment of this CBS deficiency. According to 
Ozdemir et al.29, NAC supplementation was able to 
reduce DNA damage in children with β-thalassemia. 
Yang et al.30 demonstrated by comet assay that 
incubation of cells with ochratoxin A (OTA) for 
24 h resulted in DNA strand breaks and an evident 
comet tail. Pretreatment with NAC significantly 
inhibited OTA-induced DNA strand breaks and 
reduced the formation of comets. An in vitro study 
showed that NAC was able to reduce DNA damage 
in blood of patients with symptomatic X-linked 
adrenoleukodystrophy (X-ALD), suggesting that 
the administration of this antioxidant might be 
considered as an adjuvant therapy for X-ALD31.
Oxidative stress is characterized by an 
imbalance between reactive species and antioxidant 
defenses. Free radicals cause direct damage to 
critical biomolecules, including DNA, lipids, and 
proteins23. Isoprostanes are prostaglandin (PG)-like 
compounds that are produced in vivo independently 
of cyclooxygenase enzymes, primarily by free 
radical-induced peroxidation of arachidonic acid32. 
Isoprostane measurement is the most reliable 
in vivo approach to assess lipid peroxidation, 
providing an important tool to explore the role of 
oxidative stress in the pathogenesis of diseases. 
This study demonstrated that CBS-deficient patients 
have increased urinary 15-F2t-isoprostanes levels. 
Moreover, a significant positive correlation was 
found between 15-F2t-isoprostanes and tHcy levels, 
suggesting that Hcy seems to induce oxidative 
damage in the affected patients. Homocysteine is 
readily oxidized in plasma, mainly as a consequence 
of auto-oxidation, leading to the formation of 
homocystine, homocysteine-mixed disulfides, and 
homocysteine thiolactone. It has been proposed that 
during the transition metal ion-catalyzed oxidation 
of the sulfhydryl group of Hcy, hydrogen peroxide is 
formed, which promotes oxidative stress and lipid 
peroxidation through Fenton-type reactions33,34. 
It is important to emphasize that the average tHcy 
plasma levels presented by the treated CBS-deficient 
patients of the present study was 191.3 µM, which is 
much higher than the tHcy plasma reference value 
(5-15 µM), suggesting an inappropriate metabolic 
control of the patients. Davì et al.35 demonstrated 
that urinary 8-iso-prostaglandin F2α (8-iso-PGF2α) 
excretion was significantly higher in CBS-deficient 
patients than in healthy subjects. The metabolite 
8-iso-PGF2α is a member of the F2-isoprostanes, 
a class of prostanoids that are formed by free 
radical-mediated oxidation of arachidonic acid. 
Taken together, these results suggest that lipid 
peroxidation probably may be caused by increase 
in free radicals induced by Hcy auto-oxidation.
CONCLUSION
The results found in this study allowed us to 
conclude that DNA damage with an oxidative origin 
occurs in CBS-deficient patients and that NAC has 
an important in vitro antioxidant effect on DNA 
damage induced by Hcy. Since homocystinuria 
is a rare disease, the present results should be 
confirmed with a large number of patients in a future 
study evaluating NAC as an adjuvant therapy in 
CBS deficiency.
Significance of the Study
According to the results presented in this study, 
we can suppose that DNA damage by an oxidative 
mechanism occurs in homocystinuria caused by CBS 
deficiency, as demonstrated by 8-oxo-7,8-dihydro-
2’-deoxyguanosine increased levels in affected 
patients, a parameter of oxidative damage to DNA, 
and a protective antioxidant effect of N-acetyl-L-
cysteine in this disease, as schematically shown 
in Figure 4.
Figure 4: Proposed mechanism of Hcy action on oxidative 
damage to biomolecules.
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